Abstract:Hypoxia, a common feature of the tumor microenvironment in various types of cancers, weakens cytotoxic T cell function and causes recruitment of regulatory T cells, thereby reducing tumoral immunogenicity. Studies have demonstrated that hypoxia and hypoxia-inducible factors (HIFs) 1 and 2 alpha (HIF1A and HIF2A) are involved in tumor immune escape. Under hypoxia, activation of HIF1A induces a series of signaling events, including through programmed death receptor-1/programmed death ligand-1. Moreover, hypoxia triggers shedding of complex class I chain-associated molecules through nitric oxide signaling impairment to disrupt immune surveillance by natural killer cells. The HIF-1-galactose-3-O-sulfotransferase 1-sulfatide axis enhances tumor immune escape via increased tumor cell-platelet binding. HIF2A upregulates stem cell factor expression to recruit tumor-infiltrating mast cells and increase levels of cytokines interleukin-10 and transforming growth factor-β, resulting in an immunosuppressive tumor microenvironment. Additionally, HIF1A upregulates expression of tumor-associated long noncoding RNAs and suppresses immune cell function, enabling tumor immune escape. Overall, elucidating the underlying mechanisms by which HIFs promote evasion of tumor immune surveillance will allow for targeting HIF in tumor treatment. This review discusses the current knowledge of how hypoxia and HIFs facilitate tumor immune escape, with evidence to date implicating HIF1A as a molecular target in such immune escape. This review provides further insight into the mechanism of tumor immune escape, and strategies for tumor immunotherapy are suggested.

Hostile Takeover: Manipulation of HIF-1 Signaling in Pathogen-Associated Cancers (Review)

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

HIF-1α pathway: role, regulation and intervention for cancer therapy

Regulation of hypoxia-inducible factor α in inflammation-associated diseases mediated by innate immune cells

HIF-1: structure, biology and natural modulators

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy

Targeting Hypoxia-Inducible Factor-1, for Cancer Treatment: Recent Advances in Developing Small-Molecule Inhibitors from Natural Compounds.

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma.

Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer

The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy

Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation

Polymorphisms of Hypoxia Inducible Factor-1α Gene and Susceptibility to Cancers

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism

Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape

Hypoxia-inducible Factor 1 and Breast Cancer Metastasis.

Hypoxia and Hypoxia-inducible Factor-1α:Master Regulators of Tumor Metastasis